Neoadjuvant treatment of breast cancer

Details Neoadjuvant treatment of breast cancer Neoadjuvant treatment of breast cancer

A - Human Necessities

61

K

A61K 31/704 (2006.01) A61K 31/138 (2006.01) A61K 31/337 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2497246

Neoadjuvant treatment of inflammatory or T3 to T4 breast cancer is carried out by administering to such patients a number of cycles of chemotherapy treatment in which DPPE first is administered followed by a combination of anthracyclines and taxanes.

L'invention concerne un traitement néoadjuvant du cancer du sein inflammatoire ou au stade T3 à T4 mis en oeuvre par l'administration d'un certain nombre de cycles de traitement par chimiothérapie à des patients, lequel traitement consiste à administrer en premier lieu de la DPPE puis une combinaison d'anthracyclines et de taxanes.

Affiliated with

Also associated with

Rating

Neoadjuvant treatment of breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neoadjuvant treatment of breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neoadjuvant treatment of breast cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1984776